Skip to content
We are one step closer to pharmacy benefit manager (PBM) reform. The U.S. House approved the Lower Costs, More Transparency Act (H.R. 5378) on […]
House passes Lower Costs, More Transparency Act Read More »
In October 2023, Genentech announced results from the first-ever clinical trial designed exclusively to enhance the knowledge base supporting the Black and Hispanic population
Genentech Q&A: Improving MS treatment and clinical trial diversity Read More »
Dec. 8 was a historic day for the sickle cell community and CRISPR technology, as the U.S. Food and Drug Administration (FDA) approved two
FDA approves CRISPR-based sickle cell treatment in historic decision Read More »
When it comes to oncology, nursing is the cornerstone of effective care. Nurses are often the health care professionals who provide the highest degree
How nurses in Africa are expanding cancer-care tool belts Read More »
On World AIDS Day, biotech – and the world – are reminded that we can help end HIV/AIDS through medical advances and improvements in
World AIDS Day: Biotech and equity are allies in eradicating this disease Read More »
Multiple sclerosis (MS) has long been known as an unpredictable, debilitating, and hard-to-pin-down autoimmune disease of the central nervous system. MS affects approximately 2.8
Immunic’s bid to improve the treatment of multiple sclerosis Read More »
November is National Alzheimer’s Disease Awareness Month—a time to recognize and support patients and their families and put a renewed focus on the need
Alzheimer’s Disease Awareness Month: 2023 brings progress, focus on access Read More »
The U.S. is now entering its fourth season with COVID, and the new vaccination roll-out has begun, including the option of the highly anticipated
Novavax’s Choose to Protect campaign is dedicated to driving COVID vaccination Read More »
The Federal Trade Commission (FTC) challenge of more than 100 patent listings registered with the Food and Drug Administration, mostly for devices used to
Vancouver-based biotech company Sustained Therapeutics has received regulatory clearance to continue studying a rare cancer treatment. The Biotechnology Innovation Organization (BIO) member is set
Sustainable Therapeutics’ drug delivery platform offers hope for UTUC patients Read More »
